Details - Information last confirmed on June 9, 2021

The CDC has deemed the danger of infectious pathogens as one of the top 3 largest threats to our world. The rise of multi-drug resistance infections continues to rise due to the traditional broad-spectrum antibiotic treatment methods. Our business specifically blocks the protein synthesis process through targeted treatment, preventing the replication cycle within infectious pathogens, ultimately killing only the desired microbe, maintaining healthy bacteria in the gastrointestinal(GI) tract, and preventing the the generation of antibiotic resistant infections. We have 8 issued patents and are discussing treatments to secure our food supplies with results that have been proven in treating HIV and Staph aureus. Assay results can be licensed or sold outright with exclusivity. We are capable of screening 100,000 compounds per day which is a significant reduction in the decade long screening processes currently used in the market. For more detailed information, please contact listing agent.

This is a home based/relocatable business. Seller is active in the business. Assets include 8 patents issues and an additional 5 published awaiting final approval from USPTO.

Learn More

Sign up for a free membership. Get instant access to thousands of listings. Learn about our membership plans.

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum.